दवाओं की अंतःक्रिया
Efgartigimod / hyaluronidase sc + Galcanezumab
गंभीरता: मध्यम
Efgartigimod / hyaluronidase sc and Galcanezumab: moderate interaction.
अंतिम अपडेट
केवल स्वास्थ्य पेशेवरों के लिए — मात्र संदर्भ हेतु। यह पृष्ठ संक्षिप्त सारांश है, चिकित्सकीय सलाह नहीं है और आधिकारिक लेबल या नैदानिक निर्णय का विकल्प नहीं है। दवा लिखने या देने से पहले हमेशा जाँच करें।
इस पृष्ठ की नैदानिक सामग्री केवल अंग्रेज़ी में उपलब्ध है।
सारांश
Efgartigimod blocks the neonatal Fc receptor, which normally recycles IgG and prolongs its half-life. Galcanezumab is an IgG4 antibody, so exposure and migraine prevention could be reduced. Clinical data for the combination are lacking.
इस इंटरैक्शन का सरल भाषा में अर्थ
Efgartigimod / hyaluronidase sc and Galcanezumab can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.
ऐसा क्यों होता है
FcRn blockade by efgartigimod accelerates degradation of IgG-based antibodies such as galcanezumab.
क्या करें
Monitor migraine frequency and consider an alternative non-antibody preventive if control worsens. Review the need for continued galcanezumab during efgartigimod therapy.
फार्मासिस्ट से क्या पूछें
- Should I take them at different times of day?
- Does the dose of either medicine need to change?
- Is there anything I should avoid, such as alcohol or certain foods, while on both?
Pro+ सदस्यों के लिए
पूरा पेज खोलें
Efgartigimod / hyaluronidase sc और Galcanezumab की पूरी प्रबंधन सलाह, अतिरिक्त नोट्स, साक्ष्य का विवरण और पूरे पर्चे का इंटरैक्शन चेकर खोलने के लिए खाता बनाएँ और Pro+ ट्रायल शुरू करें।
- Full clinical management advice
- Additional notes
- Evidence detail
- Interaction checker for a whole prescription
वेब पर Pro+ को 14 दिन मुफ़्त आज़माएँ। कार्ड की ज़रूरत नहीं।
Galcanezumab के अन्य इंटरैक्शन
अक्सर पूछे जाने वाले प्रश्न
Can I take Efgartigimod / hyaluronidase sc with Galcanezumab?
MediHelp rates the interaction as moderate. Efgartigimod / hyaluronidase sc and Galcanezumab can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Efgartigimod blocks the neonatal Fc receptor, which normally recycles IgG and prolongs its half-life. Galcanezumab is an IgG4 antibody, so exposure and migraine prevention could be reduced. Clinical data for the combination are lacking.
How serious is the interaction between Efgartigimod / hyaluronidase sc and Galcanezumab?
MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor migraine frequency and consider an alternative non-antibody preventive if control worsens. Review the need for continued galcanezumab during efgartigimod therapy.
What other medicines interact with Galcanezumab?
MediHelp also lists interactions of Galcanezumab with, for example, Efgartigimod alfa, Rozanolixizumab. The full list is on the Galcanezumab page.
MediHelp ऐप में पूर्ण मोनोग्राफ़, खुराक और इंटरैक्शन चेकर
MediHelp ऐप में पूरा संदर्भ खोलें, कई दवाओं की अंतःक्रियाएँ जाँचें और खुराक टूल इस्तेमाल करें।
